FIELD: medicine.
SUBSTANCE: group of invention refers to a polypeptide composition containing one or more polypeptides which are immunogenic in a vertebrate so that they induce production in the vertebrate of cells of the immune system able to recognize at least one epitope in a protein fraction of arthropod's saliva with the protein fraction of arthropod's saliva having weight of 20 kDa or less, while the polypeptides are independently specified in a polypeptide sequence SEQ ID NO:1-44 or having 7 amino acids or more partial sequences, methods for making it, using for preparing a drug.
EFFECT: group of invention is effective in treating or preventing a disease propagated by arthropods.
44 cl, 10 dwg, 21 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| SELF-ASSEMBLING PEPTIDE NANOPARTICLES EFFECTIVE AS VACCINES | 2009 |
|
RU2540871C2 |
| METHOD AND SYSTEMS FOR PREDICTION OF HLA CLASS II-SPECIFIC EPITOPES AND CD4+ T-CELL CHARACTERIZATION | 2019 |
|
RU2826261C2 |
| HELPER PEPTIDE FOR CANCER ANTIGEN | 2010 |
|
RU2588442C2 |
| RECOMBINANT pMHC MOLECULES OF CLASS II | 2017 |
|
RU2777115C2 |
| NOVEL IMMUNOTHERAPEUTIC COMPOSITION AND USE THEREOF | 2014 |
|
RU2689552C2 |
| NANOPARTICLE COMPOSITIONS FOR LONG-TERM THERAPY | 2016 |
|
RU2773380C2 |
| HUMAN GENETIC MARKERS ASSOCIATED WITH RESPONSE TO TREATMENT AGENTS THAT TARGET TOXIN B CLOSTRIDIUM DIFFICILE | 2017 |
|
RU2761249C2 |
| NOVEL PROTEIN CONJUGATE AND USE THEREOF FOR PREVENTING OR TREATING NON-ALCOHOLIC STEATOHEPATITIS, OBESITY AND DIABETES | 2021 |
|
RU2822001C1 |
| RA ANTIGEN PEPTIDES | 2004 |
|
RU2359974C2 |
| ANTIGEN-SPECIFIC HELPER T-CELL RECEPTOR GENES | 2013 |
|
RU2680588C2 |
